Lv11
30 积分 2025-05-17 加入
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
47分钟前
待确认
Targeting Modulated Vascular Smooth Muscle Cells in Atherosclerosis via FAP-Directed Immunotherapy
1小时前
已完结
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial
17天前
已完结
On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors
1个月前
已完结
T cell cholesterol transport links intestinal immune responses to dietary lipid absorption
2个月前
已完结
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
3个月前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
3个月前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
3个月前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
4个月前
已完结
Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia
4个月前
已完结
皖公网安备34019202002308
